Department of Gastroenterology and Hepatology.
Tianjin Institute of Digestive Disease.
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e727-e733. doi: 10.1097/MEG.0000000000002231.
Both sleep disturbance and frailty are common in patients with cirrhosis, but their correlation remains elusive. We aimed to investigate whether dysregulated sleep [as estimated by Pittsburgh Sleep Quality Index (PSQI)] is independently associated with frailty and their relationship in distinct subgroups.
In total 105 adult cirrhotic patients were recruited. The frailty phenotype was identified by a self-reported scale (Frailty Index) which demonstrates good validity and moderate performance based on our previous publication. Patients were categorized into frailty and nonfrailty groups according to a cut-point of 0.38 by Frailty Index. Multiple linear regression was performed to determine independent factors associated with frailty.
The median PSQI was 6.0 in the entire cohort and sleep disturbance was observed in 61 patients with cirrhosis (58.1%). Poor sleepers had a significantly higher Frailty Index than that in good sleepers (0.11 vs. 0.08; P = 0.025). In univariate analysis, PSQI score was markedly associated with the Frailty Index (β = 0.012; 95% CI, 0.006-0.018; P < 0.001), and remained significantly associated with frailty phenotype in multivariate adjustment (β = 0.010; 95% CI, 0.004-0.015; P = 0.001). The escalating PSQI scores were more prominent in frail patients, with female gender or aged 65 years and over.
Poor sleep quality is strongly associated with frailty in patients with cirrhosis. Given that sleep disturbance is modifiable, our data suggest that efficient interventions to mitigate frailty should incorporate strategies by reversing sleep dysfunction in cirrhotics with poor sleep quality.
睡眠障碍和衰弱在肝硬化患者中很常见,但它们之间的相关性仍不清楚。我们旨在研究睡眠紊乱(通过匹兹堡睡眠质量指数[PSQI]评估)是否与衰弱独立相关,以及它们在不同亚组中的关系。
共招募了 105 名成年肝硬化患者。根据我们之前发表的研究,采用自我报告的量表(衰弱指数)来确定衰弱表型,该量表具有良好的有效性和中等的性能。根据衰弱指数的截断值 0.38,将患者分为衰弱组和非衰弱组。采用多元线性回归分析确定与衰弱相关的独立因素。
整个队列的 PSQI 中位数为 6.0,105 名肝硬化患者中有 61 名(58.1%)存在睡眠障碍。睡眠质量差的患者的衰弱指数明显高于睡眠质量好的患者(0.11 比 0.08;P=0.025)。在单因素分析中,PSQI 评分与衰弱指数显著相关(β=0.012;95%CI,0.006-0.018;P<0.001),在多变量调整后仍与衰弱表型显著相关(β=0.010;95%CI,0.004-0.015;P=0.001)。PSQI 评分升高在衰弱患者中更为明显,尤其是女性或年龄在 65 岁及以上的患者。
睡眠质量差与肝硬化患者的衰弱密切相关。鉴于睡眠障碍是可以改变的,我们的数据表明,有效的干预措施应该通过逆转睡眠功能障碍来减轻衰弱,而这些干预措施应该针对那些睡眠质量差的肝硬化患者。